Newswise Feature Channel: Cancer

Immunotherapy May Boost KRAS-Targeted Therapy in Pancreatic Cancer

Perelman School of Medicine at the University of Pennsylvania — Fri, 14 Mar 2025 20:40:54 EST

Adding immunotherapy to new KRAS inhibitors boosted responses in preclinical models, setting the stage for future trials of the combination strategy. The study was published in Cancer Discovery by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

Popular Acne Skin Care Product Recalled Over Possible Cancer Causing Chemical

George Washington University — Fri, 14 Mar 2025 20:25:28 EST

ROCR Act 2025: Congress Takes Step Toward Patient-Centered, Value-Based Cancer Care with Bipartisan Plan

American Society for Radiation Oncology (ASTRO) — Fri, 14 Mar 2025 20:20:00 EST

The Radiation Oncology Case Rate (ROCR) Value Based Payment Program Act of 2025 (S.1031), sponsored by Sens. Thom Tillis (R-N.C.) and Gary Peters (D-Mich.), would protect access to high quality cancer care and improve outcomes for patients nationwide, while generating savings for Medicare. The ROCR Act provides a patient-centered solution to modernize how Medicare reimburses radiation therapy services. By shifting away from the current quantity-based, per-treatment system to patient-focused, episode-based payments, ROCR prioritizes the quality and value of care provided -- rather than the number of treatment visits.

Memorial Sloan Kettering Cancer Center Announces New State-of-the-Art Cancer Care Pavilion Will Be Named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center — Fri, 14 Mar 2025 09:10:27 EST

Memorial Sloan Kettering Cancer Center (MSK) today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.

UTEP Researchers Develop Portable, Blood-Based Device that Detects Colon Cancer

University of Texas at El Paso — Thu, 13 Mar 2025 20:50:01 EST

Scientists at The University of Texas at El Paso are developing a less invasive portable device that would use blood samples to detect colorectal cancers. Their device is described in a new study published in the journal ACS Measurement Science Au.

Mayo Clinic Researchers Identify Proteins Linked to Immunotherapy Resistance in Metastatic Colorectal Cancer

Mayo Clinic — Thu, 13 Mar 2025 20:45:38 EST

A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't been helpful for many patients with metastatic colorectal cancer. In findings published in Clinical Cancer Research, the team identified specific proteins -- fibronectin and smooth muscle actin -- within colorectal cancer tissues that are associated with resistance to immunotherapy treatment.

Mayo Clinic Laboratories and KYAN Technologies Enter a Collaboration to Expand Patients' Access to Cancer Testing

Mayo Clinic — Thu, 13 Mar 2025 20:40:51 EST

Mayo Clinic Laboratories, a global leader in advanced laboratory testing, and KYAN Technologies, a leader in functional precision medicine for oncology, today announced a collaboration to validate and provide the KYAN test, Optim.AI(tm), across the United States. This collaboration aims to support clinicians with additional testing insights for cancer treatment.

Using Nanotech as a Way of Differentiating Cells From One Another

University of Rhode Island — Thu, 13 Mar 2025 20:40:04 EST

Early diagnosis is crucial in disease prevention and treatment. Many diseases can be identified not just through physical signs and symptoms but also through changes at the cellular and molecular levels. When it comes to a majority of chronic conditions early detection, particularly at the cellular level, gives patients a better chance for successful treatment.

Re-Purposed FDA-Approved Drug Could Help Treat High-Grade Glioma

Michigan Medicine - University of Michigan — Thu, 13 Mar 2025 20:30:39 EST

A study, published in Cancer Cell, shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States Food and Drug Administration to treat gastrointestinal stromal tumors with a PDGFRA exon 18 mutation as well advanced systemic mastocytosis and indolent systemic mastocytosis.

Moffitt Study Finds New Immunotherapy Strategy for Enhancing Melanoma Treatment

Moffitt Cancer Center — Thu, 13 Mar 2025 20:30:28 EST

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO.

NBA Hall Of Famer Dwayne Wade Details His Kidney Cancer Diagnosis and Symptoms & Surgery

Hackensack Meridian Health — Thu, 13 Mar 2025 20:20:05 EST

Researchers at Case Western Reserve University Identify RNA Molecule as Possible Driver of Gastric Cancer

Case Western Reserve University — Thu, 13 Mar 2025 09:00:54 EST

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer--among the world's deadliest forms of the disease.

Spotiphy Integrative Analysis Tool Turns Spatial RNA Sequencing Into Imager

St. Jude Children's Research Hospital — Wed, 12 Mar 2025 20:10:55 EST

Spatial transcriptomics is a cutting-edge technique that characterizes gene expression within sections of tissue, such as heart, skin or liver tissue. Scientists at St. Jude and the University of Wisconsin-Madison today share a generative algorithm for achieving both high genome and image resolution.

New Guideline on Gastric Premalignant Cancer Published by the American College of Gastroenterology

American College of Gastroenterology (ACG) — Wed, 12 Mar 2025 19:50:37 EST

The American College of Gastroenterology has published its first clinical guideline on the diagnosis and management of gastric premalignant conditions (GPMC), including endoscopic surveillance, risk stratification, resection, the role of H. pylori infection, risk reduction, and management of autoimmune gastritis and gastric epithelial polyps.

Expert Available: Protecting Your Skin While on Spring Break

George Washington University — Wed, 12 Mar 2025 18:50:14 EST

Skin cancer is the most common type of cancer in the United States. According to the Skin Cancer Foundation, one in five Americans will develop skin cancer by the age of 70. ...

American College of Radiology to Launch Early Lung Cancer Detection Registry

American College of Radiology (ACR) — Wed, 12 Mar 2025 18:45:20 EST

The ACR Lung Cancer Screening Registry will expand and evolve into the Early Lung Cancer Detection Registry to support actionable incidental pulmonary nodules management. Half of patients with lung cancer found as an IPN are not eligible for screening. 60% of IPN patients are lost to follow-up.

Cancer Interception: The First HPV Antiviral Treatment Fights Pre-Cancers

University of New Mexico Comprehensive Cancer Center — Wed, 12 Mar 2025 18:35:11 EST

Like a football team disrupting the opponent's play, Michelle Ozbun, PhD, and Jason McConville, PhD, at the UNM Comprehensive Cancer Center are designing a gel to prevent cancers caused by human papillomaviruses (HPVs). No other antiviral treatments for HPV diseases are available.

A Michigan Medicine Dosimetry Code Ready for Widespread Use in Software

Michigan Medicine - University of Michigan — Wed, 12 Mar 2025 12:30:42 EST

A code developed at the University of Michigan is now helping patients in FDA-cleared software.

MD Anderson Research Highlights for March 12, 2025

University of Texas MD Anderson Cancer Center — Wed, 12 Mar 2025 12:00:31 EST

The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

The "POR-DEE" Mask: A Health Innovation by Chula's Faculty of Medicine, in Collaboration with CP, Effectively Protects Against PM2.5 Dust at an Affordable Price

Chulalongkorn University — Wed, 12 Mar 2025 08:55:33 EST

Due to the PM2.5 dust situation in Thailand, which now exceeds the global standard and significantly impacts public health, Chulalongkorn University's Faculty of Medicine and Chulalongkorn Hospital, Thai Red Cross Society, have developed the "POR-DEE" face mask.